The main priority for Public Health is to develop a SARS-CoV-2 vaccine that is both effective and safe. Researchers used self-assembling ferritin nanoparticles that displayed one of two multimerized SARS-CoV-2 spikes and full-length ectodomain to design subunit vaccine candidates. After immunizing mice with the two spikes, it showed that titration occurs, and antibodies in them prove effective as it titers twofold more than those contained in COVID-19 patient’s convalescent plasma when SARS-CoV-2 is used. At the same time, S-Fer was more responsive in terms of its neutralizing power. However, taking the two showed better results, and this would help researchers strategize on how to design an effective single dosage vaccine.
Introduction
SARS-CoV-2 pandemic has affected every nation all over the globe and has disrupted everyone’s life. As a result, there have been over 24 million confirmed cases and more than 825,000 deaths all over the world. The only and most effective way to combat the disease is to create an effective, safe, and affordable vaccine for mass distribution. COVID-19 patients show solid neutralizing antibody responses to the virus’ spike, which makes the SARS-CoV-2 the main target of the vaccines that will be antibody-based. A polypeptide breaks down to form two subunits, and these are responsible for receptor binding. The receptor-binding domain (RBD), when used separately, proves to be a useful part of the vaccine development.
Many platforms are being employed to help make an effective and safe vaccine, such as nucleic vaccines and subunit vaccines. However, these vaccines are understood to have more negatives than positives, but it still remains the better option. These vaccines have less batch variability and less batch variability; nevertheless, they are associated with adverse events and frequent side effects. In the research, they used a full-length ectodomain spike, and it shows conformation flexibility, and it can therefore be used to enhance immunogenicity. To prove this, they compared it with a purified antigen and monomeric RBD; results from this test indicated a considerably higher neutralizing antibody response. A single dose of S-Fer showed that neutralization was two times higher than that in plasma from convalescent COVID-19 patients. More importantly, when the results proved that taking these spikes together in a single dose should be the foundation upon which the scientists should develop the SARS-CoV-2 subunit vaccines. The main point from this is to ascertain that using spike-functionalized ferritin nanoparticles show an improved response from the antibodies in comparison with spike timers as well as RBD when used alone.